TABLE 1.
Gene | Tumor (cases) | Normal (cases) | Fold change | t-test | p-value | Dataset |
---|---|---|---|---|---|---|
STAT1 a | Hepatocellular carcinoma (Josahkian et al., 2018) | Liver (10) | 4.016 | 5.967 | 1.23E-6*, a | Wurmbach et al. |
Hepatocellular carcinoma (Lokau et al., 2019) | Liver (19) | 2.540 | 9.395 | 2.96E-13*, a | Mas et al. | |
STAT2 | Hepatocellular carcinoma (225) | Liver (220) | −1.101 | −4.655 | 1.000 | Roessler et al. |
STAT3 a | Hepatocellular carcinoma (Lokau et al., 2019) | Liver (19) | −2.290 | −6.908 | 4.66E-9*, a | Mas et al. |
STAT4 | Hepatocellular carcinoma (Lokau et al., 2019) | Liver (19) | 1.128 | 1.257 | 0.108 | Mas et al. |
STAT5A | Hepatocellular carcinoma (Josahkian et al., 2018) | Liver (10) | −1.078 | −1.293 | 0.896 | Wurmbach et al. |
STAT5B | Hepatocellular carcinoma (103) | Liver (75) | 1.097 | 1.626 | 0.053 | Chen et al. |
STAT6 | Hepatocellular carcinoma (103) | Liver (75) | −1.163 | −2.314 | 0.989 | Chen et al. |
These results are statistically significant. *p-value <0.001.